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ABSTRACT 
Upper eyelid retraction is a characteristic feature of thyroid eye disease, including Graves’ orbitopathy. In this study, a 
new surgical technique for correction of lid retraction secondary to Graves’ orbitopathy is described. Sixteen eyelids of 
patients older than 18 years old underwent surgical correction for moderate to severe lid retraction secondary to Graves’ 
orbitopathy. In this procedure, levator aponeurectomy was performed via a transconjunctival approach. Upper marginal 
reflex distance (MRD1) was measured before the surgery and at 1 week, 3 months, and 6 months after the surgery. 
MRD1 was reduced significantly from preoperatively (mean: 7.84 mm) to 1 week after the surgery (mean: 3.59 mm) (P < 
0.001). Three and six months after surgery, mean MRD1 was 5.09 mm and 5.10 mm, respectively, showing that lid 
retraction was improved significantly (P < 0.001). Lateral levator aponeurectomy via the transconjunctival approach is a 
simple, scar-less, quick procedure that has optimal stable outcome. 
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INTRODUCTION
Graves’ ophthalmopathy is an organ-specific 
autoimmune disorder that leads to inflammatory 
swelling and lymphocytic infiltration in the orbit, causing 
fibrosis and mucopolysaccharide deposition in the orbital 
connective tissue. Lid retraction, lid margin malposition, 
proptosis, limitation of extraocular muscle motility, optic 
nerve compression, chemosis, blood vessel congestion, 
and corneal exposure are typical orbital signs and 
symptoms of the disease [1-3]. Upper eyelid retraction is 
a characteristic feature of thyroid eye disease (TED) [4-6]. 
Lid retraction is defined as an abnormally high positioned 
lid in the affected eye in primary gaze [7, 8]. This 
condition can cause exposure keratopathy and its 
disturbing symptoms; it also results in staring faces, 
aggressive appearance, and limited scope for cosmetic 
surgery [5, 6, 9]. The mechanism of upper eyelid 
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retraction can be secondary to levator muscle 
contracture due to inflammation and fibrosis. Lid 
retraction may be related to the degree of associated 
proptosis, which may act as a wedge [5, 10, 11]. Another 
possible mechanism is hyperaction of Müller’s muscle 
caused by sympathetic enhancement due to high level of 
thyroid hormones [11, 12]. Treatment of Graves’ 
orbitopathy is surgical and non-surgical. Non-surgical 
management of Graves’ orbitopathy includes anti-
inflammatory drugs, which, however, may not result in 
complete resolution and symptom relief. Orbital 
decompression, correction of squinted eye, lid 
lengthening, and blepharoplasty are steps of the surgical 
approach to Graves’ orbitopathy. Surgery may help 
patients, but it is best to perform it in the inactive phase 
of the systemic disease [13]. While upper lid retraction is 
one of the most common symptoms requiring surgery in 
Graves’ orbitopathy, there is still no consensus regarding 
the best technique [2]. Surgical procedures that can 
achieve a predictable height and contour of the lid 
remain a challenge for orbit surgeons. Hence, various 
techniques have been reported, including anterior or 
posterior recession or resection of Müller’s muscle 
and/or the levator muscle or its aponeurosis, full 
thickness blepharotomy, levator lengthening by 
placement of a spacer that can be natural or synthetic, 
and marginal myotomy [4, 14]. Nonetheless, weakening 
or lengthening of the upper lid retractors is the basis of 
all techniques. In this study, we describe the results of a 
new surgical technique using lateral levator 
aponeurectomy via a transconjunctival approach in 
patients with upper eyelid retraction secondary to 
Graves’ orbitopathy. 
MATERIALS AND METHODS 
This prospective clinical study of patients with moderate 
to severe eyelid retraction due to Graves’ orbitopathy 
was conducted at the Feiz Eye Hospital and the 
Department of Ophthalmology, Isfahan University of 
Medical Sciences, Isfahan, Iran from October 2015 to 
October 2016. All surgeries were performed by a single 
surgeon (AZ). Inclusion criteria were patients requiring 
surgical correction of upper eyelid retraction due to 
thyroid orbitopathy, patients with a stable thyroid state 
(as confirmed in laboratory and clinical experiments) for 
at least 6 months, and patients with no previous lid 
surgery. Patients who had previous lid surgery, age less 
than 18 years, or active or uncontrolled disease and 
patients who did not come for follow-up visits were 
excluded. The study protocol and ethical issues was 
approved by the institutional review board of Isfahan 
University of Medical Sciences. All participants 
underwent full examination prior to surgery. All the 
important harmful effects or unintended effects related 
to the surgery, as well as the novelty of the surgical 
technique, were completely explained to the patients. 
Written informed consent was obtained from all 
participants before the surgery. Patient age, sex, eye 
(right or left), and follow-up visits were recorded. In each 
visit, slit-lamp examination for exposure keratopathy and 
measurement of upper marginal reflex distance (MRD1) 
were recorded. Presence of exposure keratopathy was 
recorded as 'yes' or 'no'. MRD1 measurement was 
recorded in millimeters (mm) preoperatively and at each 
follow-up visit. Complications associated with the surgery 
were noted in each visit. Statistical analyses were 
performed using STATA version 11 (State Corp., College 
station, TX) and all considered P-values were two-sided. 
 
 
Figure 1: The First Step in Transconjunctival Lateral Levator 
Aponeurectomy Includes Lid Eversion and Incision Just Above the 
Tarsal Palate from the Lateral Margin 
 
Figure 2: The Second Step in Transconjunctival Lateral Levator 
Aponeurectomy Includes the Dissection of the Conjunctiva and 
Müller’s Muscle and the Surgical Excision of the Levator Aponeurosis 
 
Surgical Technique 
Assessment of the ocular surface status and presence or 
absence of exposure keratopathy and measurement of 
MRD1 in seating position and in primary position were 
performed before the surgery. Surgery was performed 
under light sedation because of the need of a patient’s 
cooperation during the surgery, to reach symmetry 
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between the two eyelids. The upper eyelid was 
anesthetized locally by injection of lidocaine 1% and 
1:200000 adrenalin with a 30-gauge needle in 
subcutaneous tissue. The lid was everted by using a 
Desmarres lid retractor and the palpebral conjunctiva 
was exposed. The upper border of the tarsal palate was 
identified and an incision was made immediately above 
the tarsal palate from the lateral margin to the center of 
the lid at 1/2 to 1/3 of the upper lid length based on the 
intensity of lid retraction with a #15 knife (Fig 1). 
 
 
Figure 3: The Size of the Surgically excised Levator Aponeurosis during 
Transconjunctival Lateral Levator Aponeurectomy has the Same 
Length of the First Incision and 5 mm of Width 
 
The conjunctiva and Müller’s muscle under the 
conjunctiva were dissected with a Westcott scissor to 
reach the levator muscle aponeurosis. After exposing the 
levator aponeurosis, it was surgically excised (Fig 2) with 
the same length of the first incision and 5 mm of width 
(Fig 3). The conjunctiva and Müller’s muscle were 
returned to their primary position. Patients were asked 
to attend the follow-up visits at 1 week and 3 and 6 
months after the surgery. MRD1 was measured and 
recorded in each visit. 
RESULTS 
This study included 16 eyes of 16 patients with Graves’ 
ophthalmopathy. All patients completed the study and 
were considered for final analysis. The age of the 
patients ranged between 29 and 60 years old (Table 1). 
 
Table 1: Demographic Data of Patients with Graves’ Ophthalmopathy 
 Values 
Age (years) 45.06 ± 8.77 
Age Range 29–60 
Sex  
Male 4 (25) 
Female 12 (75) 
Eye  
Right 9 (56.2) 
Left 7 (43.8) 
Date presented as mean ± SD or No (%). 
 
Pre-operative MRD1 was 6.00–11.00 mm (mean: 7.84 
mm). One week after the surgery, MRD1 was 2.00–4.50 
mm (mean: 3.59 mm) (Table 1). This difference was 
statistically significant (P < 0.001) (Table 2). 
Three and six months after surgery, MRD1 was 4.50–6.00 
mm (mean: 5.09 mm) and 4.50–6.00 mm (5.10 mm), 
respectively (P < 0.001). There were no major or 
persistent complications related to the surgery. None of 
the patients had exposure keratopathy before or after 
the surgery. 
 
Table 2: Upper Marginal Reflex Distance (MRD1) Measurements Before and After the Surgery in Patients with Graves’ Ophthalmopathy 
MRD1 Range (mm) Mean (mm) ± SD 
Before the surgery 6.00–11.00 7.84 ± 1.35 
After the surgery   
1 week 2.00–4.50 3.59 ± 0.82 
3 months 4.50–6.00 5.09 ± 0.52 
6 months 4.50–6.00 5.10 ± 0.77 
 
DISCUSSION
Upper eyelid retraction is the chief morbidity of Graves’ 
ophthalmopathy, which can result in exposure 
keratopathy, proptosis, and cosmetic malformations. The 
aim of surgical correction of lid retraction is to prevent 
and treat keratopathy, relief ocular discomfort, and 
return the patient’s appearance [2]. Upper eyelid 
retraction is multifactorial and can be divided into two 
main categories: 1) anterior lamella involvement due to 
tissue loss or scaring that contract the skin and 
orbicularis oculi muscle, secondary to superficial injuries 
such as burns; and 2) levator mechanism shortening due 
to overactivity of Müller’s muscle with/without levator 
muscle. The latter type occurs most commonly secondary 
to Graves’ ophthalmopathy [7]. With the progression of 
the disease, levator and Müller’s muscles are affected by 
inflammatory processes, resulting in muscle overactivity. 
This stage leads to variable lid retraction without 
evidence of lid lag. Tissue changes and development of 
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fibrosis in retractors of the lid terminate in restrictive 
patterns of lid retraction [8]. Eyelid retraction cannot be 
corrected completely by medication. The surgical 
techniques used for upper lid retraction are divided into 
the transconjunctival (posterior) approach to resect 
Müller’s muscle and the transcutaneous (anterior) 
approach through an eyelid crease to resect the levator 
muscle and its aponeurosis along with Müller’s muscle 
[7, 13]. The choice of surgical method depends on the 
degree of retraction and the experience of the surgeon. 
In 1923, Goldstein described levator recession and in 
1959, Berke suggested tenotomy for upper eyelid 
retraction [15]. Henderson described his surgical 
technique in 1965. This procedure consisted of a 
mullerectomy via conjunctival approach and then graded 
division of the levator aponeurosis fibers from the 
anterior surface of the tarsus plate. Henderson’s 
procedure is quick and does not need suturing, and 
because of the simple anatomy of the operation, it is still 
commonly used in the clinical setting. Olver and Fells 
reviewed Henderson’s procedure in the Moorfield Eye 
Hospital to identify the most appropriate patients for this 
procedure. They concluded that the procedure should be 
reserved for mild and symmetric (or near symmetrical) 
lid retractions that have no significant lateral flare. This 
surgery is done on superior and anterior tarsal plate. 
Therefore, it cannot correct lateral contour flare [5]. In 
1983, Hurwitz and Rodgers reported the use of 
mullerectomy for mild retraction, mullerectomy 
combined with levator aponeurosis weakening for 
moderate retraction, and either mullerectomy and 
levator aponeurectomy or scleral graft implantation for 
severe retraction [16]. Contrary to the study of Hurwitz 
and Rodgers, in our study, levator aponeurectomy was 
performed using a transconjunctival approach. 
Therefore, in our patients, the technique was scales and 
had an acceptable clinical cosmetic outcome. We also did 
not use levator aponeurosis weakening or synthetic 
mesh as a spacer for surgical approach, which could have 
increased the risk of adhesion secondary to the 
procedure. 
Small suggested a new surgical technique in 1988, called 
the proximal levator technique. In this procedure, the 
levator muscle proximal to Whitnall’s ligament is divided 
and then fixed with an adjustable suture [15, 17]. In this 
study, we reported a new surgical technique for 
correcting lid retraction in Graves’ ophthalmopathy. One 
week after the surgery, the mean MRD1 was reduced by 
4.25 mm from the pre-operative measurement. We 
followed the patients 3 months after the surgery and the 
mean MRD1 was 5.09 mm, which means that the 
patient’s lid achieved the optimal position after 3 
months. The change of the lid position and the significant 
differences of the post-operative MRDs raise the 
question that this change was secondary to normal 
recovery of edema of manipulated soft tissues or to 
surgical regression. For certainty of the stability of the 
surgical result, we decided to measure MRD1 6 months 
after the surgery. Mean MRD1 was 5.10 mm, which was 
similar to the measurement at 3 months after surgery. 
The major limitations of this study were its cross-
sectional nature and the small number of cases as well as 
absence of a control group. 
In conclusion, we propose this simple, scar-less, quick 
surgical technique as a beneficial procedure for treating 
lid retraction stably. 
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